High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs

Nucleos(t)ide analogs are used for preventing liver cirrhosis in chronic hepatitis B patients, but the risk factors of hepatocellular carcinoma (HCC) in these patients remain unclear. We designed this retrospective cohort study, the aim is to determine the risk factors for HCC development and its im...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Lin, Ching-Chung, Bair, Ming-Jong, Liu, Chia-Yuan, Lin, Ze-Yu, Chen, Chih-Jen, Chen, Ming-Jen, Chu, Cheng-Hsin, Wang, Horng-Yuan, Shih, Shou-Chuan, Wang, Tsang-En
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344209/
https://ncbi.nlm.nih.gov/pubmed/30608393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013818
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller